Is this your company? Get featured or correct your listing →
Recent changes
- Oct 26, 2026Oct 26, 2026IPO $377M SEC EDGAR
Debt, IPO & other events
not counted in equity raised| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Oct 26, 2026 | ipo | $377M | — | RTW InvestmentsLeadunverifiedNew Enterprise Associates (NEA)LeadunverifiedSR One Capital ManagementLeadunverifiedRA CapitalLeadunverifiedInvusLeadunverified | SEC EDGAR |
Investors
Latest Pulse
- Oct 28, 2026IPO Market Splits: Jio's $131.9B Debut, Microcaps Near $50MJio's $131.9 billion debut, Anthropic's pending S-1, a $50 million Aclaris follow-on offering and a $377 million Corxel SPAC show 2026 public-market deals splitting into mega-deals and microcaps, with little priced in between.→
- Oct 26, 2026Corxel Pharma to Go Public Via $377M Amanat SPAC DealCorxel Pharmaceuticals, developer of obesity drug candidate CX11, will go public in the US through a SPAC merger with Amanat Acquisition Corp expected to deliver roughly $377 million in combined trust and PIPE proceeds.→
Coverage Timeline
newest firstAll Coverage
Value Add Research
- Fundraising · Oct 29, 2026Corxel Pharmaceuticals IPO 2026: $377M Amanat SPAC Deal
- VC & Investing · Oct 20, 2026Lycia Therapeutics IPO 2026: $938M Valuation, LYCA Ticker
- Market & Trends · Oct 15, 2026Agility Robotics IPO 2026: $2.5B SPAC Deal With Churchill Capital
- Market & Trends · Jun 14, 2026GLP-1 Drug Startups 2026: $157B Market and $471M VC Funding
Related Companies
Sources & methodologyshow
Where these figures come from
- SEC EDGARprimary source1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.